Gaston Capital

Auto Parts Nearby is a service designed to assist users in locating, researching, and purchasing auto parts and accessories that are currently in stock at nearby physical stores. The platform allows users to input their location, vehicle specifications, and part details to receive information about local retailers and pricing. By utilizing a proprietary catalog and search engine based on zip code, Auto Parts Nearby enables customers to easily find the required auto parts from various retailer brands in their vicinity.

Mobility Designed, LLC is a manufacturer and distributor of innovative mobility devices, primarily focusing on crutches tailored for individuals facing mobility challenges. Established in 2014 and headquartered in Kansas City, Missouri, the company aims to enhance user comfort by addressing the pain and discomfort associated with traditional mobility aids. Its designs promote non-weight-bearing compliance, allowing users to navigate restricted mobility without pain, thereby improving adherence to medical directives. Through its commitment to creating more effective mobility solutions, Mobility Designed seeks to empower users and improve their overall quality of life.

A professional staffing and work-to-hire firm based in Gastonia, North Carolina, with locations in Lincolnton, Shelby, Statesville and Hickory. It places skilled and semi-skilled labor in manufacturing, assembly and clerical roles across Western North Carolina for various industries. The firm was acquired by Gaston Capital.

Intezyne Technologies, Inc. is a clinical-stage biotechnology company based in Tampa, Florida, specializing in drug development for cancer treatments. Founded in 2004, the company utilizes its IVECT Method, a nanotechnology platform designed to enhance the anti-tumor activity of chemotherapeutics specifically within tumors. Intezyne's product portfolio includes various compounds that employ cellular and molecular targeting, featuring tumor-specific release mechanisms. Key candidates in its pipeline include IT-139, which targets the GRP78 pathway, IT-141, a micelle nanoparticle aimed at metastatic solid tumors, and IT-147, an epothilone-D encapsulated within the IVECT micelle. Additionally, Intezyne is advancing preclinical research initiatives focused on the delivery of DNA and siRNA, as well as molecularly targeted drugs and orally administered IVECT therapeutics. The company's innovative approach aims to significantly improve the efficacy of cancer treatments through its proprietary drug delivery systems.

First Capital Surety & Trust Company (“First Capital”) is an independent state-chartered trust company with its charter situs being South Dakota. First Capital’s business is to serve as trustee and trust administrator for Settlement Trusts and Wealth Management Trusts, i.e. financial and estate planning trusts. Pursuant to South Dakota statute, First Capital may